Discontinuation report MORPHINE SULFATE INJECTION USP
Report ID | 114045 |
Drug Identification Number | 00636908 |
Brand name | MORPHINE SULFATE INJECTION USP |
Common or Proper name | MORPHINE SULFATE INJECTION USP |
Company Name | ICU MEDICAL CANADA INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | MORPHINE SULFATE |
Strength(s) | 1MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 10 |
ATC code | N02AA |
ATC description | OPIOIDS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | |
Actual discontinuation date | 2020-05-04 |
Remaining supply date | 2019-03-31 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2600 BOUL ALFRED-NOBEL, SUITE 100 SAINT LAURENT, QUEBEC CANADA H4S 0A9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v3 | 2020-05-05 | English | Compare |
v2 | 2020-05-04 | French | Compare |
v1 | 2020-05-04 | English | Compare |
Showing 1 to 3 of 3